Correlation Between Lifecore Biomedical and Petros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lifecore Biomedical and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifecore Biomedical and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lifecore Biomedical and Petros Pharmaceuticals, you can compare the effects of market volatilities on Lifecore Biomedical and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifecore Biomedical with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifecore Biomedical and Petros Pharmaceuticals.
Diversification Opportunities for Lifecore Biomedical and Petros Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lifecore and Petros is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Lifecore Biomedical and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Lifecore Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifecore Biomedical are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Lifecore Biomedical i.e., Lifecore Biomedical and Petros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lifecore Biomedical and Petros Pharmaceuticals
Given the investment horizon of 90 days Lifecore Biomedical is expected to generate 0.39 times more return on investment than Petros Pharmaceuticals. However, Lifecore Biomedical is 2.59 times less risky than Petros Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 790.00 in Lifecore Biomedical on August 25, 2024 and sell it today you would lose (59.00) from holding Lifecore Biomedical or give up 7.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lifecore Biomedical vs. Petros Pharmaceuticals
Performance |
| Timeline |
| Lifecore Biomedical |
| Petros Pharmaceuticals |
Lifecore Biomedical and Petros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lifecore Biomedical and Petros Pharmaceuticals
The main advantage of trading using opposite Lifecore Biomedical and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifecore Biomedical position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.| Lifecore Biomedical vs. Shuttle Pharmaceuticals | Lifecore Biomedical vs. Catalent | Lifecore Biomedical vs. Tilray Inc | Lifecore Biomedical vs. Kamada |
| Petros Pharmaceuticals vs. Eliem Therapeutics | Petros Pharmaceuticals vs. HCW Biologics | Petros Pharmaceuticals vs. RenovoRx | Petros Pharmaceuticals vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |